Active Immunotherapy as a Potential Anticancer Treatment

Hybrid was selected by Dendreon Corporation and their agency Euro RSCG Life Central to create a 2-minute animation detailing Dendreon’s development of active immunotherapy as a potential anticancer treatment.

This presentation also discusses the potential that lies in harnessing the power of the body’s own immune response and the significance of using antigen presenting cells as a means of preparing T-cells for activation.

The project was set up and produced in a way that enabled our clients to take any of the characters seen in the MOA and re-purpose them for use in a major print campaign that included large-scale booth display panels, sales brochures, stickers, and even a custom die-cut CD.

The animation was presented at the ASCO conference and the sponsoring company distributed the sales brochures and CDs to healthcare professionals.